We are pleased to announce that, effective 24 November 2020, Fidelio Capital AB (“Fidelio”) has completed the acquisition of Premune AB’s (“Premune”) shares in Nextmune. Through the transaction, Fidelio will increase its ownership in Nextmune and become the majority owner. Nextmune is a leading company within specialty pharmaceuticals for companion animals with sales in over 75 markets worldwide.
With Fidelio as the majority owner, Nextmune will have the support and resources to continue to invest in innovation and R&D and to broaden its product portfolio. The transaction will not lead to any operational changes in the company, which will continue to run in the same way as today.
Fidelio looks forward to continuing to support Nextmune on its journey to improve the quality of life for companion animals around the world.
Vegner Group Limited is a leading residential property management group in the UK with 475 employees, over 100,000 homes under management and a nationwide reach across 20 office locations. Vegner specializes in serving Residents Management Company (RMC) clients, bringing further
Read moreFidelio Capital acquires 10 million shares, around 2.2 percent of the capital, in the animal health company Vimian Group AB, effective 21 September 2023. Through the transaction, Fidelio will increase its ownership in Vimian, from 53 percent of the capital
Read moreOdevo, an international leader that is driving change in the traditional property management industry, continues its rapid expansion in the US market with the addition of the leading property manager in the Carolinas, William Douglas Management. William Douglas manages over
Read more